Suppr超能文献

马立克氏病病毒的 LORF9 参与 B 淋巴细胞的早期裂解复制,并且可以作为基因缺失疫苗开发的靶标。

LORF9 of Marek's disease virus is involved in the early cytolytic replication of B lymphocytes and can act as a target for gene deletion vaccine development.

机构信息

College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.

International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, China.

出版信息

J Virol. 2023 Dec 21;97(12):e0157423. doi: 10.1128/jvi.01574-23. Epub 2023 Nov 28.

Abstract

Marek's disease virus (MDV) is a highly infectious and oncogenic virus that can induce severe T cell lymphomas in chickens. MDV encodes more than 100 genes, most of which have unknown functions. This work indicated that the gene is necessary for MDV early cytolytic replication in B lymphocytes. In addition, we have found that the deletion mutant has a comparative immunological protective effect with CVI988/Rispens vaccine strain against very virulent MDV challenge. This is a significant discovery that LORF9 can be exploited as a possible target for the development of an MDV gene deletion vaccine.

摘要

马立克氏病病毒(MDV)是一种高度传染性和致癌性的病毒,可在鸡中诱导严重的 T 细胞淋巴瘤。MDV 编码 100 多个基因,其中大多数功能未知。这项工作表明,该基因对于 MDV 在 B 淋巴细胞中的早期细胞裂解复制是必需的。此外,我们发现,与 CVI988/Rispens 疫苗株相比, 缺失突变体对超强毒力 MDV 攻击具有相当的免疫保护作用。这是一项重要的发现,LORF9 可以作为开发 MDV 基因缺失疫苗的潜在靶点。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验